Low-dose curcumin leads to the inhibition of tumor growth via enhancing CTL-mediated antitumor immunity (Q39557788)

13 September 2017

title

Low-dose curcumin leads to the inhibition of tumor growth via enhancing CTL-mediated antitumor immunity (English)

1 reference

13 September 2017

0 references

Feifei Luo

1

1 reference

13 September 2017

Xiao Song

2

1 reference

13 September 2017

Yi Zhang

3

1 reference

13 September 2017

Yiwei Chu

4

1 reference

13 September 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21497674

30 November 2024

publication date

15 April 2011

1 reference

full work available at URL

13 September 2017

https://api.elsevier.com/content/article/PII:S1567576911001652?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.INTIMP.2011.04.002

https://api.elsevier.com/content/article/PII:S1567576911001652?httpAccept=text/plain

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.INTIMP.2011.04.002

International Immunopharmacology

30 November 2024

published in

1 reference

13 September 2017

volume

11

1 reference

13 September 2017

issue

9

1 reference

13 September 2017

page(s)

1234-1240

1 reference

Estimates of the cancer incidence and mortality in Europe in 2006.

13 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.INTIMP.2011.04.002

30 November 2024

Cancer statistics, 2007

2

1 reference

https://api.crossref.org/works/10.1016/J.INTIMP.2011.04.002

Curcumin and cancer: an "old-age" disease with an "age-old" solution

30 November 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.INTIMP.2011.04.002

Pharmacology of Curcuma longa

30 November 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.INTIMP.2011.04.002

Inhibition of invasion and induction of apoptosis by curcumin in H-ras-transformed MCF10A human breast epithelial cells

30 November 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.INTIMP.2011.04.002

Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis

30 November 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.INTIMP.2011.04.002

Bax and Bak genes are essential for maximum apoptotic response by curcumin, a polyphenolic compound and cancer chemopreventive agent derived from turmeric, Curcuma longa.

30 November 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.INTIMP.2011.04.002

Curcumin-induced GADD153 gene up-regulation in human colon cancer cells

30 November 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.INTIMP.2011.04.002

Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice

30 November 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.INTIMP.2011.04.002

Antiangiogenic agents: studies on fumagillin and curcumin analogs

30 November 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.INTIMP.2011.04.002

"Spicing up" of the immune system by curcumin

30 November 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.INTIMP.2011.04.002

Biological effects of curcumin and its role in cancer chemoprevention and therapy

30 November 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.INTIMP.2011.04.002

Inhibition of proliferation and apoptosis of human and rat T lymphocytes by curcumin, a curry pigment

30 November 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.INTIMP.2011.04.002

Immunomodulatory activity of curcumin: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production in vitro

30 November 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.INTIMP.2011.04.002

Regression of established murine carcinoma metastases following vaccination with tumour-associated antigen peptides

30 November 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.INTIMP.2011.04.002

Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance

30 November 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.INTIMP.2011.04.002

Involvement of cellular death in TRAIL/DR5-dependent suppression induced by CD4(+)CD25(+) regulatory T cells

30 November 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.INTIMP.2011.04.002

Inhibition of tumor growth and vasculogenic mimicry by curcumin through down-regulation of the EphA2/PI3K/MMP pathway in a murine choroidal melanoma model

30 November 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.INTIMP.2011.04.002

Dietary curcumin attenuates glioma growth in a syngeneic mouse model by inhibition of the JAK1,2/STAT3 signaling pathway

30 November 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.INTIMP.2011.04.002

Antigen delivery by alpha(2)-macroglobulin enhances the cytotoxic T lymphocyte response

30 November 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.INTIMP.2011.04.002

Isolation and expansion of human adenovirus-specific CD4+ and CD8+ T cells according to IFN-gamma secretion for adjuvant immunotherapy

30 November 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.INTIMP.2011.04.002

Curcumin inhibits immunostimulatory function of dendritic cells: MAPKs and translocation of NF-kappa B as potential targets

30 November 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.INTIMP.2011.04.002

Immunomodulatory effects of curcumin

30 November 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.INTIMP.2011.04.002

The three Es of cancer immunoediting

30 November 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.INTIMP.2011.04.002

Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists

30 November 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.INTIMP.2011.04.002

Immunomodulatory effects of curcumin: in-vivo

30 November 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.INTIMP.2011.04.002

Inhibition of intestinal tumors by curcumin is associated with changes in the intestinal immune cell profile

30 November 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.INTIMP.2011.04.002

Curcumin prevents tumor-induced T cell apoptosis through Stat-5a-mediated Bcl-2 induction

30 November 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.INTIMP.2011.04.002

Inhibition of homodimerization of Toll-like receptor 4 by curcumin

30 November 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.INTIMP.2011.04.002

Gene expressions of Toll-like receptor 2, but not Toll-like receptor 4, is induced by LPS and inflammatory cytokines in mouse macrophages

30 November 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.INTIMP.2011.04.002

Dietary curcumin and limonin suppress CD4+ T-cell proliferation and interleukin-2 production in mice.

30 November 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.INTIMP.2011.04.002

Curcumin inhibits mitogen stimulated lymphocyte proliferation, NFkappaB activation, and IL-2 signaling

30 November 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.INTIMP.2011.04.002

Curcumin reverses T cell-mediated adaptive immune dysfunctions in tumor-bearing hosts

30 November 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.INTIMP.2011.04.002

Tumor-induced oxidative stress perturbs nuclear factor-kappaB activity-augmenting tumor necrosis factor-alpha-mediated T-cell death: protection by curcumin.

30 November 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.INTIMP.2011.04.002

30 November 2024

Identifiers

1 reference

13 September 2017

1 reference